UBS Reiterates Buy Rating on Boston Scientific (BSX)

Boston Scientific Corporation (NYSE:BSX) is one of the 14 Best Large Cap Stocks to Invest In Now. On December 17, UBS reiterated its Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept the price target at $140. This update comes even as the shares experienced a drop over the past month.

UBS analyst Danielle Antalffy believes that the risk/reward profile for Boston Scientific Corporation (NYSE:BSX) is “increasingly skewed to the upside” heading into 2026. This view is supported by the firm’s opinion that high-growth business areas will be able to sustain the recent momentum.

According to UBS, the company’s Electrophysiology (EP) division, which makes up about 17% of the company’s 2025 estimated sales, is expected to slow in 2026. However, the research firm pointed out that Boston Scientific Corporation’s (NYSE:BSX) CEO Mike Mahoney is committed to growing this division higher than market rates, estimated at 20-25%.

The company’s CEO has also voiced a firm belief in sustained double-digit growth for the WATCHMAN device, which represents about 10% of estimated sales in 2025. Mahoney is confident about this even before the upcoming CHAMPION data readout, which is expected in spring 2026.

UBS thinks Boston Scientific Corporation (NYSE:BSX) is in a good position to guide 2026 sales growth higher than its long-range target of 10-12%. This potential upside in 2026 is expected to come mainly from the WATCHMAN business.

Boston Scientific Corporation (NYSE:BSX) is an American biotechnology and biomedical engineering company that offers a portfolio of devices and therapies that help physicians diagnose and treat cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.

While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Most Promising Fintech Stocks to Invest In and 15 Best Technology Penny Stocks to Buy.

Disclosure: None. This article is originally published at Insider Monkey.